Coffee Break| More...
 

Generic Medication

Key Democrats Back BIO Industry Against Consumers to Delay Generic Medicines (Biosimilars)

James Love | Posted 08.16.2009 | Politics

Read More: Senator Kennedy, Biosimilars, Anna Eshoo, John Conyers, Generic Medication, Politics News
James Love

Unlike for pharmaceutical drugs, there is no easy way to get FDA approval for a generic biologic product. Congress is considering an FDA reform to fix this, but it is being derailed by the BIO.

Read Post

Dollars & Health: Cashing In On Generics

Andrea Chalupa | Posted 08.15.2009 | Living

Read More: Walletpop, Andrea-Chalupa, Andy-Miller, Generic Medication, Generic vs Namebrands, Generic Drugs, Prescription Drugs, Health Care Reform, Atlanta Journal-Constitution, WalletPop.Com, Generic Versus Namebrands, Andy Miller, Buying Generic Prescription Drugs, Andrea Chalupa, Living News
Andrea Chalupa

Andy Miller, formerly a health care reporter for the Atlanta Journal-Constitution, has joined Walletpop as a watch dog for all things health care and...

Read Post

Generic Swap Meet

Barbara Dehn | Posted 04.25.2009 | Politics

Read More: Epilepsy-Drugs, Health Insurance, Generic Drugs, Generic Medication, Prescription Drugs, Insurance Companies, Prescription Meds, Prescriptions, Meds, Generic Prescriptions, Health Care, Patient-Care, Health-Insurance, Healthcare, Politics News
Barbara Dehn

I understand the need to cut costs, but in my opinion, some insurance companies are practicing health care without a license. They have none of the liability and yet are part of the decision-making? What's up with that?

Read Post

Pfizer May Get Into Bidding For Ranbaxy, Generic Drug Maker

Reuters | Posted 06.21.2008 | Business

Read More: Big Pharma, Fizer, Ranbaxy, Generic Medication, Pfizer Generic, Fizer Generic, Generic Drugs, Pfizer, Business News

MUMBAI (Reuters) - Pfizer may bid for Ranbaxy Laboratories, countering a $4.6 billion (2.4 billion pound) offer by Japan's Daiichi Sankyo for the Indi...

Read Whole Story